USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name: Applied Immune Sciences, Inc.
City: Santa Clara
State: CA
Zip+4: 95054
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
Website URL: N/A
Phone: N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $185,238.00 4
SBIR Phase II $926,900.00 2

Award List:

AN ANTIGEN-SPECIFIC IMMUNE DEVICE FOR MYASTHENIA GRAVIS

Award Year / Program / Phase: 1990 / SBIR / Phase I
Agency: HHS
Principal Investigator: Sohel Talib
Award Amount: $50,000.00
Abstract:
Although myasthenia gravis (mg) is the best characterized human autoimmune disease, no cure is available. antibodies to nicotinic acetylcholine receptors (achrs) of muscle are detectable in 90 percent of patients and cause the weakness of mg. antibody levels can be decreased by plasmapheresis, and… More

PURIFICATION OF PERIPHERAL BLOOD STEM CELLS

Award Year / Program / Phase: 1991 / SBIR / Phase I
Agency: HHS
Principal Investigator: Lebkowski, Jane S , Principal Investigator
Award Amount: $49,800.00

PROPAGATION OF RECOMBINANT ADENO-ASSOCIATED VIRUS VECTOR

Award Year / Program / Phase: 1992 / SBIR / Phase I
Agency: HHS
Principal Investigator: Jane S Lebkowski
Award Amount: $50,000.00

PURIFICATION OF PERIPHERAL BLOOD STEM CELLS

Award Year / Program / Phase: 1993 / SBIR / Phase II
Agency: HHS
Principal Investigator: Lebkowski, Jane S , Principal Investigator
Award Amount: $426,900.00
Abstract:
Applied immune sciences, inc. has developed sterile polystyrene devices onto which monoclonal antibodies are covalently attached. these devices are routinely used to rapidly separate cells with surface antigens specific for the immobilized antibody. moreover, these devices have been used… More

PROPAGATION OF RECOMBINANT ADENO-ASSOCIATED VIRUS VECTOR

Award Year / Program / Phase: 1993 / SBIR / Phase II
Agency: HHS
Principal Investigator: Jane S Lebkowski
Award Amount: $500,000.00
Abstract:
Recombinant adeno-associated virus (raav) vectors have been used to introduce genetic material into a variety of cell types and are a good candidate for multipurpose, safe dna transduction system. the spacific aim of the research is to develop a system to very simply produce high titer recombinant… More

Purification and Culture of Dendritic Langerhans Cells

Award Year / Program / Phase: 1993 / SBIR / Phase I
Agency: HHS
Principal Investigator: David A. Okrongly
Award Amount: $35,438.00
Abstract:
Methods for obtaining highly purified Langerhans Cells (LC) directly from epidermis or by directed differentiation of CD34+ progenitor cells are proposed. Development and commercialization of products for LC purification will aid basic research on the role of LC in skin diseases such as psoriasis,… More